Might this be the significantly expanded clinical program for AZD0466 we’ve all been waiting for?
https://clinicaltrials.gov/ct2/show/NCT04865419
Estimated enrollment: 160 participants
Estimated study start date: April 30, 2021
Estimated study completion date: October 31, 2024
Astra Zeneca Quarterly, page-17
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.8¢ |
Change
0.001(1.03%) |
Mkt cap ! $40.97M | |||
| Open | High | Low | Value | Volume |
| 9.7¢ | 9.9¢ | 9.7¢ | $44.76K | 455.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 824859 | 9.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.0¢ | 121525 | 5 |
View Market Depth
| Last trade - 16.10pm 04/11/2024 (20 minute delay) ? |
| SPL (ASX) Chart |